UMF

Cluj-Napoca, Romania
Cluj-Napoca, Romania

Time filter

Source Type

News Article | May 23, 2017
Site: globenewswire.com

BOULDER, Colo., May 23, 2017 (GLOBE NEWSWIRE) -- UMF Group Inc. (OTC Pink:UMFG) (“the Company”) is pleased to provide a corporate update exemplifying a change in the direction of the business from Oil and Gas Exploration to Medical Marijuana. UMF Group Inc. would like to welcome Nicole Merion, Director of Business Development, to the company. Nicole Merion brings a wealth of scientific knowledge and contacts at the highest levels of academia and production, facilitating UMF Group Inc.’s vision of operating at the cutting edge of technology and research. She also brings a history of production and development to the company and has been working in the Cannabis field for the past ten years. The company has shifted to an innovative Medical Marijuana company, which aims to develop and approve proprietary extracts as pharmaceuticals, and to ultimately deliver to the market pharmaceuticals that are highly differentiated both from medical marijuana and from current cannabinoid drugs. UMF Group Inc. maintains a proprietary “whole plant” method of extracting various cannabinoids from the marijuana plant and converting them into higher quality and quantity. Several important events have led to the opportunity of a lifetime for Cannabis Cultivators and Industry Innovators. UMF Group Inc. is poised to make significant strides in the years to come. The US medical cannabis market generated $6.7 billion in sales in 2016, with sales expected to grow to $21.8 billion by 2020. Due to the rapidly changing American situation, with recent favorable legislative changes, in the US, medical cannabis is now legal in 28 states. The opportunity for market capitalization is not limited to America. Global legal cannabis markets are expected to grow to $140.5 billion in 2020 from $28.8 billion in 2015 according to global market firm Technavio. The Medical Marijuana industry is about to go global and UMF Group Inc. is positioned to be a market leader. FORWARD LOOKING STATEMENT This news release includes forward-looking statements that reflect UMF Group Inc. current expectations about its future results, performance, prospects and opportunities UMF Group Inc. has tried to identify these forward-looking statements by using words and phrases such as "may", "will", "expects", "anticipates", "believes", "intends", "estimates", "should", "typical", "we are confident" or similar expressions. These forward-looking statements are based on information currently available to UMF Group Inc. and are subject to a number of risks, uncertainties and other factors that could cause the Company's actual results, performance, prospects of opportunities in the remainder of 2017 and beyond, to differ materially from those expressed in, or implied by, these forward-looking statements.


News Article | May 23, 2017
Site: globenewswire.com

BOULDER, Colo., May 23, 2017 (GLOBE NEWSWIRE) -- UMF Group Inc. (OTC Pink:UMFG) (“the Company”) is pleased to provide a corporate update exemplifying a change in the direction of the business from Oil and Gas Exploration to Medical Marijuana. UMF Group Inc. would like to welcome Nicole Merion, Director of Business Development, to the company. Nicole Merion brings a wealth of scientific knowledge and contacts at the highest levels of academia and production, facilitating UMF Group Inc.’s vision of operating at the cutting edge of technology and research. She also brings a history of production and development to the company and has been working in the Cannabis field for the past ten years. The company has shifted to an innovative Medical Marijuana company, which aims to develop and approve proprietary extracts as pharmaceuticals, and to ultimately deliver to the market pharmaceuticals that are highly differentiated both from medical marijuana and from current cannabinoid drugs. UMF Group Inc. maintains a proprietary “whole plant” method of extracting various cannabinoids from the marijuana plant and converting them into higher quality and quantity. Several important events have led to the opportunity of a lifetime for Cannabis Cultivators and Industry Innovators. UMF Group Inc. is poised to make significant strides in the years to come. The US medical cannabis market generated $6.7 billion in sales in 2016, with sales expected to grow to $21.8 billion by 2020. Due to the rapidly changing American situation, with recent favorable legislative changes, in the US, medical cannabis is now legal in 28 states. The opportunity for market capitalization is not limited to America. Global legal cannabis markets are expected to grow to $140.5 billion in 2020 from $28.8 billion in 2015 according to global market firm Technavio. The Medical Marijuana industry is about to go global and UMF Group Inc. is positioned to be a market leader. FORWARD LOOKING STATEMENT This news release includes forward-looking statements that reflect UMF Group Inc. current expectations about its future results, performance, prospects and opportunities UMF Group Inc. has tried to identify these forward-looking statements by using words and phrases such as "may", "will", "expects", "anticipates", "believes", "intends", "estimates", "should", "typical", "we are confident" or similar expressions. These forward-looking statements are based on information currently available to UMF Group Inc. and are subject to a number of risks, uncertainties and other factors that could cause the Company's actual results, performance, prospects of opportunities in the remainder of 2017 and beyond, to differ materially from those expressed in, or implied by, these forward-looking statements.


News Article | May 23, 2017
Site: globenewswire.com

BOULDER, Colo., May 23, 2017 (GLOBE NEWSWIRE) -- UMF Group Inc. (OTC Pink:UMFG) (“the Company”) is pleased to provide a corporate update exemplifying a change in the direction of the business from Oil and Gas Exploration to Medical Marijuana. UMF Group Inc. would like to welcome Nicole Merion, Director of Business Development, to the company. Nicole Merion brings a wealth of scientific knowledge and contacts at the highest levels of academia and production, facilitating UMF Group Inc.’s vision of operating at the cutting edge of technology and research. She also brings a history of production and development to the company and has been working in the Cannabis field for the past ten years. The company has shifted to an innovative Medical Marijuana company, which aims to develop and approve proprietary extracts as pharmaceuticals, and to ultimately deliver to the market pharmaceuticals that are highly differentiated both from medical marijuana and from current cannabinoid drugs. UMF Group Inc. maintains a proprietary “whole plant” method of extracting various cannabinoids from the marijuana plant and converting them into higher quality and quantity. Several important events have led to the opportunity of a lifetime for Cannabis Cultivators and Industry Innovators. UMF Group Inc. is poised to make significant strides in the years to come. The US medical cannabis market generated $6.7 billion in sales in 2016, with sales expected to grow to $21.8 billion by 2020. Due to the rapidly changing American situation, with recent favorable legislative changes, in the US, medical cannabis is now legal in 28 states. The opportunity for market capitalization is not limited to America. Global legal cannabis markets are expected to grow to $140.5 billion in 2020 from $28.8 billion in 2015 according to global market firm Technavio. The Medical Marijuana industry is about to go global and UMF Group Inc. is positioned to be a market leader. FORWARD LOOKING STATEMENT This news release includes forward-looking statements that reflect UMF Group Inc. current expectations about its future results, performance, prospects and opportunities UMF Group Inc. has tried to identify these forward-looking statements by using words and phrases such as "may", "will", "expects", "anticipates", "believes", "intends", "estimates", "should", "typical", "we are confident" or similar expressions. These forward-looking statements are based on information currently available to UMF Group Inc. and are subject to a number of risks, uncertainties and other factors that could cause the Company's actual results, performance, prospects of opportunities in the remainder of 2017 and beyond, to differ materially from those expressed in, or implied by, these forward-looking statements.


News Article | June 12, 2017
Site: globenewswire.com

BOULDER, Colo., June 12, 2017 (GLOBE NEWSWIRE) -- UMF Group Inc. (OTC Pink:UMFG) (“the Company”) is pleased to announce that internal testing and research is being conducted in preparation for patent applications. UMF Group Inc. is an innovative Medical Marijuana company, which aims to develop and approve particular extracts as pharmaceuticals. The company is conducting data analysis for the proprietary “whole plant” method of extracting various cannabinoids from the marijuana plant and converting them into higher quality and quantity. The patent application relates to the extraction of pharmaceutically active components from plant materials, and more particularly to the preparation of a botanical drug substance (BDS) for incorporation in to a medicament. It also relates to a BDS, for use in pharmaceutical formulations. In particular it relates to BDS comprising cannabinoids obtained by extraction from cannabis. Recently, public interest in Cannabis as medicine has been growing, based in no small part on the fact that Cannabis has long been considered to have medicinal properties, ranging from treatment of cramps, migraines, convulsions, appetite stimulation and attenuation of nausea and vomiting. In fact, a report issued by the National Academy of Sciences' Institute of Medicine indicated that the active components of Cannabis appear to be useful in treating pain, nausea, muscle spasms in multiple sclerosis as well as other problems. The global demand is growing exponentially and the increasing interest amongst the academic researchers and healthcare providers regarding the therapeutic uses of marijuana is among the significant factors driving the international market over the coming years. A 2017 report from Grand View Research, Inc. estimates that the global medical marijuana market will reach a value of $55.8 billion by 2025. FORWARD LOOKING STATEMENT This news release includes forward-looking statements that reflect UMF Group Inc. current expectations about its future results, performance, prospects and opportunities UMF Group Inc. has tried to identify these forward-looking statements by using words and phrases such as "may", "will", "expects", "anticipates", "believes", "intends", "estimates", "should", "typical", "we are confident" or similar expressions. These forward-looking statements are based on information currently available to UMF Group Inc. and are subject to a number of risks, uncertainties and other factors that could cause the Company's actual results, performance, prospects of opportunities in the remainder of 2017 and beyond, to differ materially from those expressed in, or implied by, these forward-looking statements.


News Article | May 30, 2017
Site: globenewswire.com

BOULDER, Colo., May 30, 2017 (GLOBE NEWSWIRE) -- UMF Group Inc. (UMFG) (OTC Pink:UMFG) (“the Company”) is pleased to announce the launch of a corporate website. As our society is becoming more digital based, it is necessary to have a predominant presence on the Internet.  UMF Group Inc.’s newly launched corporate website www.umfgroupinc.com is an efficient, and effective marketing tool and an improved visitor experience. By continuing to add high quality content will enable our search engine rankings to improve as well as branding, generating greater sales, and improved customer loyalty. The company also benefits from reduced operating costs such as rents, rates and labor and are thus able to pass these savings on to the consumer. Central access to otherwise decentralized, retained information and the option to personalize content for target user groups will provide the right type of information supporting the client in their research and purchase of our proprietary whole plant extraction products.  Whole-Plant Cannabis concentrates has become the “Gold Standard”, according to Medical Jane (an online educational resource for patients, caregivers, and health care professionals in the legal cannabis industry). Patients are reporting incredible success stories from whole-plant extracts, these patients typically use whole-plant concentrates in the form of RSO, tinctures, solvent-less wax, and more. FORWARD LOOKING STATEMENT This news release includes forward-looking statements that reflect UMF Group Inc. current expectations about its future results, performance, prospects and opportunities UMF Group Inc. has tried to identify these forward-looking statements by using words and phrases such as "may", "will", "expects", "anticipates", "believes", "intends", "estimates", "should", "typical", "we are confident" or similar expressions. These forward-looking statements are based on information currently available to UMF Group Inc. and are subject to a number of risks, uncertainties and other factors that could cause the Company's actual results, performance, prospects of opportunities in the remainder of 2017 and beyond, to differ materially from those expressed in, or implied by, these forward-looking statements.


News Article | July 18, 2017
Site: marketersmedia.com

WiseGuyReports.Com Publish a New Market Research Report On - “Manuka Honey: Global Market Sales, Consumption, Demand and Forecast 2017 – 2022”.Pune, India - July 18, 2017 /MarketersMedia/ — This report studies the Manuka Honey market. Manuka honey, produced in Australia and New Zealand by bees that pollinate the Manuka bush, is one of the most unique and beneficial forms of honey in the world. The honey is commonly sold as an alternative medicine. There are many Manuka honey uses that range from healing sore throats and digestive illnesses, to curing Staph infections and gingivitis. Get a Sample Report @ https://www.wiseguyreports.com/sample-request/931947-global-manuka-honey-market-forecast-to-2022 For more information or any query mail at sales@wiseguyreports.com Scope of the Report: This report focuses on the Manuka Honey in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Comvita Manuka Health Arataki Honey Watson & Son Streamland Pure Honey New Zealand KirksBees Honey Capilano Nature’s Way Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Columbia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers UMF 5+ / MGO 83 mg/kg (ppm) UMF 10+ / MGO 263 mg/kg (ppm) UMF 15+ / MGO 514 mg/kg (ppm) UMF 20+ / MGO 829 mg/kg (ppm) Others Market Segment by Applications, can be divided into Digestion & Inflammation Treatment Wound-care & Skincare Products Others Report Details @ https://www.wiseguyreports.com/reports/931947-global-manuka-honey-market-forecast-to-2022 There are 15 Chapters to deeply display the global Manuka Honey market. Chapter 1, to describe Manuka Honey Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Manuka Honey, with sales, revenue, and price of Manuka Honey, in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Manuka Honey, for each region, from 2012 to 2017; Continue…… Table Of Contents – Major Key Points 1 Market Overview 1.1 Manuka Honey Introduction 1.2 Market Analysis by Type 1.2.1 UMF 5+ / MGO 83 mg/kg (ppm) 1.2.2 UMF 10+ / MGO 263 mg/kg (ppm) 1.2.3 UMF 15+ / MGO 514 mg/kg (ppm) 1.2.4 UMF 20+ / MGO 829 mg/kg (ppm) 1.2.5 Others 1.3 Market Analysis by Applications 1.3.1 Digestion & Inflammation Treatment 1.3.2 Wound-care & Skincare Products 1.3.3 Others 1.4 Market Analysis by Regions 1.4.1 North America (USA, Canada and Mexico) 1.4.1.1 USA Market States and Outlook (2012-2022) 1.4.1.2 Canada Market States and Outlook (2012-2022) 1.4.1.3 Mexico Market States and Outlook (2012-2022) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2012-2022) 1.4.2.2 France Market States and Outlook (2012-2022) 1.4.2.3 UK Market States and Outlook (2012-2022) 1.4.2.4 Russia Market States and Outlook (2012-2022) 1.4.2.5 Italy Market States and Outlook (2012-2022) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2012-2022) 1.4.3.2 Japan Market States and Outlook (2012-2022) 1.4.3.3 Korea Market States and Outlook (2012-2022) 1.4.3.4 India Market States and Outlook (2012-2022) 1.4.3.5 Southeast Asia Market States and Outlook (2012-2022) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2012-2022) 1.4.4.2 Egypt Market States and Outlook (2012-2022) 1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022) 1.4.4.4 South Africa Market States and Outlook (2012-2022) 1.4.4.5 Nigeria Market States and Outlook (2012-2022) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Comvita 2.1.1 Business Overview 2.1.2 Manuka Honey Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 Comvita Manuka Honey Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 Manuka Health 2.2.1 Business Overview 2.2.2 Manuka Honey Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2 2.2.3 Manuka Health Manuka Honey Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 Arataki Honey 2.3.1 Business Overview 2.3.2 Manuka Honey Type and Applications 2.3.2.1 Type 1 2.3.2.2 Type 2 2.3.3 Arataki Honey Manuka Honey Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 Watson & Son 2.4.1 Business Overview 2.4.2 Manuka Honey Type and Applications 2.4.2.1 Type 1 2.4.2.2 Type 2 2.4.3 Watson & Son Manuka Honey Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 Streamland 2.5.1 Business Overview 2.5.2 Manuka Honey Type and Applications 2.5.2.1 Type 1 2.5.2.2 Type 2 2.5.3 Streamland Manuka Honey Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 Pure Honey New Zealand 2.6.1 Business Overview 2.6.2 Manuka Honey Type and Applications 2.6.2.1 Type 1 2.6.2.2 Type 2 2.6.3 Pure Honey New Zealand Manuka Honey Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 KirksBees Honey 2.7.1 Business Overview 2.7.2 Manuka Honey Type and Applications 2.7.2.1 Type 1 2.7.2.2 Type 2 2.7.3 KirksBees Honey Manuka Honey Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8 Capilano 2.8.1 Business Overview 2.8.2 Manuka Honey Type and Applications 2.8.2.1 Type 1 2.8.2.2 Type 2 2.8.3 Capilano Manuka Honey Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9 Nature’s Way 2.9.1 Business Overview 2.9.2 Manuka Honey Type and Applications 2.9.2.1 Type 1 2.9.2.2 Type 2 2.9.3 Nature’s Way Manuka Honey Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 Global Manuka Honey Market Competition, by Manufacturer 3.1 Global Manuka Honey Sales and Market Share by Manufacturer 3.2 Global Manuka Honey Revenue and Market Share by Manufacturer 3.3 Market Concentration Rate 3.3.1 Top 3 Manuka Honey Manufacturer Market Share 3.3.2 Top 6 Manuka Honey Manufacturer Market Share 3.4 Market Competition Trend Continued….. For more information or any query mail at sales@wiseguyreports.com Buy 1-User PDF@ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=931947 ABOUT US: Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories. Contact Info:Name: Norah TrentEmail: sales@wiseguyreports.comOrganization: WiseGuy Research Consultants Pvt Ltd.Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune - 411028Phone: +1-646-845-9349 Source URL: http://marketersmedia.com/manuka-honey-global-market-sales-consumption-demand-and-forecast-2017-2022/218818For more information, please visit https://www.wiseguyreports.comSource: MarketersMediaRelease ID: 218818


News Article | July 22, 2017
Site: marketersmedia.com

Wiseguyreports.Com Adds “Manuka Honey -Market Demand, Growth, Opportunities and Analysis of Top Key Player Forecast To 2022” To Its Research Database This report studies Manuka Honey in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering By types, the market can be split into UMF 5+ UMF 10+ UMF 15+ UMF 20+ Others By Application, the market can be split into Digestion and inflammation treatment Wound-care & skincare products Other uses By Regions, this report covers (we can add the regions/countries as you want) North America China Europe Southeast Asia Japan India If you have any special requirements, please let us know and we will offer you the report as you want. Global Manuka Honey Market Professional Survey Report 2017 1 Industry Overview of Manuka Honey 1.1 Definition and Specifications of Manuka Honey 1.1.1 Definition of Manuka Honey 1.1.2 Specifications of Manuka Honey 1.2 Classification of Manuka Honey 1.2.1 UMF 5+ 1.2.2 UMF 10+ 1.2.3 UMF 15+ 1.2.4 UMF 20+ 1.2.5 Others 1.3 Applications of Manuka Honey 1.3.1 Digestion and inflammation treatment 1.3.2 Wound-care & skincare products 1.3.3 Other uses 1.4 Market Segment by Regions 1.4.1 North America 1.4.2 China 1.4.3 Europe 1.4.4 Southeast Asia 1.4.5 Japan 1.4.6 India 8 Major Manufacturers Analysis of Manuka Honey 8.1 Comvita 8.1.1 Company Profile 8.1.2 Product Picture and Specifications 8.1.2.1 Product A 8.1.2.2 Product B 8.1.3 Comvita 2016 Manuka Honey Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.1.4 Comvita 2016 Manuka Honey Business Region Distribution Analysis 8.2 Manuka Health 8.2.1 Company Profile 8.2.2 Product Picture and Specifications 8.2.2.1 Product A 8.2.2.2 Product B 8.2.3 Manuka Health 2016 Manuka Honey Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.2.4 Manuka Health 2016 Manuka Honey Business Region Distribution Analysis 8.3 Arataki Honey 8.3.1 Company Profile 8.3.2 Product Picture and Specifications 8.3.2.1 Product A 8.3.2.2 Product B 8.3.3 Arataki Honey 2016 Manuka Honey Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.3.4 Arataki Honey 2016 Manuka Honey Business Region Distribution Analysis 8.4 Watson & Son 8.4.1 Company Profile 8.4.2 Product Picture and Specifications 8.4.2.1 Product A 8.4.2.2 Product B 8.4.3 Watson & Son 2016 Manuka Honey Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.4.4 Watson & Son 2016 Manuka Honey Business Region Distribution Analysis 8.5 Streamland 8.5.1 Company Profile 8.5.2 Product Picture and Specifications 8.5.2.1 Product A 8.5.2.2 Product B 8.5.3 Streamland 2016 Manuka Honey Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.5.4 Streamland 2016 Manuka Honey Business Region Distribution Analysis 8.6 Pure Honey New Zealand 8.6.1 Company Profile 8.6.2 Product Picture and Specifications 8.6.2.1 Product A 8.6.2.2 Product B 8.6.3 Pure Honey New Zealand 2016 Manuka Honey Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.6.4 Pure Honey New Zealand 2016 Manuka Honey Business Region Distribution Analysis 8.7 KirksBees Honey 8.7.1 Company Profile 8.7.2 Product Picture and Specifications 8.7.2.1 Product A 8.7.2.2 Product B 8.7.3 KirksBees Honey 2016 Manuka Honey Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.7.4 KirksBees Honey 2016 Manuka Honey Business Region Distribution Analysis 8.8 Capilano 8.8.1 Company Profile 8.8.2 Product Picture and Specifications 8.8.2.1 Product A 8.8.2.2 Product B 8.8.3 Capilano 2016 Manuka Honey Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.8.4 Capilano 2016 Manuka Honey Business Region Distribution Analysis 8.9 Nature's Way 8.9.1 Company Profile 8.9.2 Product Picture and Specifications 8.9.2.1 Product A 8.9.2.2 Product B 8.9.3 Nature's Way 2016 Manuka Honey Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.9.4 Nature's Way 2016 Manuka Honey Business Region Distribution Analysis For more information, please visit https://www.wiseguyreports.com/sample-request/1508315-global-manuka-honey-market-professional-survey-report-2017


News Article | July 31, 2017
Site: www.PR.com

Missouri City, TX, July 31, 2017 --( The second leg of UMF series, Unijamz Old School Concert, is in September, and the last portion of UMF series, Unijamz October Fest – Evening Under the Stars, will follow in mid-October, dates and time to be announced. Texans come out to celebrate and help others. Portions of all the Tex-Giving UMF series proceeds will be donated to selected charities (B.I.G. Love Cancer Care, The 100 Club, American Foundation for Suicide Prevention (AFSF), Heroes for Children.org, Ronald McDonald House, Boys and Girls Club, and Schools Bullying Programs). School supplies will go to all the youth attendees at the Unijamz’s Back 2 School Concert. – A Back to School Concert Experience - you don’t want to miss! Come out to Connect with the All-star line-up: Dae Dae, Silento, Iheart Memphis, Jermaine Dupri's Lifetime TV “the rap game” artists Jayla Marie and Young Lyric the Houston Princess, music by I heart radio 93.7 the beat DJ Mr. Rogers, the youngest national touring and radio hosts DJ Young Music and more celebrity guest appearances. The Unijamz Music Festival occurs on August 26, 2017 and serves as the inaugural event of the highly anticipated music festival season. This premier musical and cultural sensation is proudly performed by some of the hottest charting artists. The Unijamz experience is complemented by plentiful fans, incredible state of the art sound and video production with a special laser light and many other inviting attractions, which make Unijamz a “must attend” event. Its partners are committed to producing an extraordinary experience for our supporters and sponsors. The Unijamz brand has extended its reach domestically and regionally by way of an aggressive marketing campaign and meticulous attention taken by the sponsorship team. Sponsors have face-to-face activation opportunities at UMF and access to exceptional promotional strategies that utilize current social media platforms to reach their highly sought-after audience of active consumers. Their goal is to create an atmosphere where sponsors exceed their promotional objectives and thrive! Xcelsior Productions is eager to partner with you for Houston’s 1st Annual Unijamz Music Festival. For more information visit: www.unijamz.com facebook.com/unijamztx @unijamztx #unijamztx Missouri City, TX, July 31, 2017 --( PR.com )-- The 1st Annual Unijamz Music Festival (UMF) in the Greater Houston Area is a 3-part charity concert series kicking off on August 26,2017 at Xcelsior Sports Athletic Grounds (the Home of the Houston Dynamo – Houston Dash Youth (South) Soccer Academy), 14503 Fondren Road, Missouri City, TX 77489. The Unijamz Back 2 School “Anti-Bullying” Charity Concert is from 12 p.m. to 8 p.m. Tickets are on sale now www.unijamz.com.The second leg of UMF series, Unijamz Old School Concert, is in September, and the last portion of UMF series, Unijamz October Fest – Evening Under the Stars, will follow in mid-October, dates and time to be announced.Texans come out to celebrate and help others. Portions of all the Tex-Giving UMF series proceeds will be donated to selected charities (B.I.G. Love Cancer Care, The 100 Club, American Foundation for Suicide Prevention (AFSF), Heroes for Children.org, Ronald McDonald House, Boys and Girls Club, and Schools Bullying Programs). School supplies will go to all the youth attendees at the Unijamz’s Back 2 School Concert.– A Back to School Concert Experience - you don’t want to miss!Come out to Connect with the All-star line-up: Dae Dae, Silento, Iheart Memphis, Jermaine Dupri's Lifetime TV “the rap game” artists Jayla Marie and Young Lyric the Houston Princess, music by I heart radio 93.7 the beat DJ Mr. Rogers, the youngest national touring and radio hosts DJ Young Music and more celebrity guest appearances.The Unijamz Music Festival occurs on August 26, 2017 and serves as the inaugural event of the highly anticipated music festival season. This premier musical and cultural sensation is proudly performed by some of the hottest charting artists. The Unijamz experience is complemented by plentiful fans, incredible state of the art sound and video production with a special laser light and many other inviting attractions, which make Unijamz a “must attend” event. Its partners are committed to producing an extraordinary experience for our supporters and sponsors. The Unijamz brand has extended its reach domestically and regionally by way of an aggressive marketing campaign and meticulous attention taken by the sponsorship team. Sponsors have face-to-face activation opportunities at UMF and access to exceptional promotional strategies that utilize current social media platforms to reach their highly sought-after audience of active consumers. Their goal is to create an atmosphere where sponsors exceed their promotional objectives and thrive! Xcelsior Productions is eager to partner with you for Houston’s 1st Annual Unijamz Music Festival.For more information visit:www.unijamz.comfacebook.com/unijamztx@unijamztx#unijamztx Click here to view the list of recent Press Releases from Xcelsior Productions, LLC.


News Article | November 14, 2016
Site: www.marketwired.com

BROSSARD, QUEBEC--(Marketwired - Nov. 14, 2016) - Diagnos Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, celebrates today the World Diabetes Day by announcing a pilot in partnership with Mexico's National Social Security System. The public-private partnership (PPP) for the pilot involves both sides commitments: from one side the Mexican Social Security Institute's (IMSS for Spanish) Head Office, Entailment Department, Department of Chief Medical Officer along with its several divisions: Special National Health Projects, Primary-Secondary-and Tertiary level of attention divisions, as well as the National Coordination of Ophthalmology; from the other side DIAGNOS' proprietary artificial intelligence Computer Assisted Retinal Analysis (CARA) and its Wellness Program: hardware, CARA platform and specialized staff in eye care to manage diabetics and operate our technology, IT Department, senior management entrusted by its shareholders and board of directors. IMSS provides social security to over 71 Million people nationwide in Mexico. The purpose of the pilot for the public health authority is to collect evidence such as avoidance of blindness of at least 95% of diabetics' cases, avoid wrong referral of patients to the specialist, time reduction for an appointment to the specialist within the following 48 hours (instead of 8 months), control and monitor of diabetics, provide a solid database, unburden diabetes costs which nowadays surpass $ 96 Million Mexican pesos per day (approx. $ 4.6 Million US dollars), among others. As well specialists and observers of the pilot will certify CARA's performance for automatic detection, biometrics and telemedicine friendly connectivity, by accessing randomly to patients' results. In the automatic detection the specialists will provide feedback in terms of sensitivity and specificity minding that DIAGNOS has quality certifications and approvals from COFEPRIS in Mexico, FDA in the US, Health Canada, to mention a few. In biometrics and telemedicine friendly connectivity, the specialists will look after its integration to IMSS Digital program on how doctors and patients interact by safeguarding the management of information. "DIAGNOS is proud to collaborate with IMSS for a pilot starting at World Diabetes Day: in 3 weeks we'll screen patients within 2 family medicine units (UMF) of IMSS' first level of attention. Both parties are investing time and resources to run successfully run it in order to set the principles for a strategic alliance by fitting DIAGNOS' Wellness Program powered by our CARA platform into IMSS' flagship diabetes programs: DiabetIMSS and PrevenIMSS. We're confident that the outcome of this pilot will be beneficial for the Mexican diabetics entitled with social security coverage within the national territory," said André Larente, President of DIAGNOS. Mr. Larente also added "Our health IT technology was made to be accessible to all people around the world with diabetes or pre-diabetes condition, our vision is to provide universal coverage and we keep our efforts every day to achieve it". After gathering conclusions from the pilot, IMSS will evaluate the feasibility for a multi-annual contract starting in 2017 with different business models: fix in clinics, mobile and the ignition of the National Ophthalmology Centre in order to provide specific eye care to a minimum of 1.5 to 5 Million diabetics. Founded in 1998, DIAGNOS is a publicly traded Canadian corporation with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including healthcare and natural resources. CARA is a tele-ophthalmology platform that integrates with existing equipment (hardware and software) and processes at the point of care (POC) and comprises: image upload, image enhancement automated pre-screening, grading by a specialist, and referral to a specialist. CARA's image enhancement algorithms make standard retinal images sharper, clearer, and easier to read. CARA is accessible securely over the internet, and is compatible with all recognized image formats and brands of fundus cameras, and is EMR compatible. CARA is a cost-effective tool for screening large numbers of patients, in real-time and has been approved by regulatory authorities including Health Canada, US Food and Drug Administration, and the European Union. This document contains forward-looking information. There can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in these statements. Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. For further information, please contact DIAGNOS, visit our website at www.diagnos.com, or visit the SEDAR website at www.sedar.com.


News Article | December 2, 2016
Site: www.newsmaker.com.au

This report studies ENT Chairs in Global Market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, China, Japan, India, Korea, Southeast Asia, Australia, Brazil, Middle East and Africa,  focuses on the top Manufacturers in each country, covering  Atmos Medical  Heinemann Medizintechnik  Haag Streit  Optomic  Chammed  Global Surgical  BOKEER  Mega Medical  Nagashima Medical  Arsimed Medical  Innotech Medical  Olsen  Tecnodent  UMF Medical Market Segment by Countries, this report splits Global into several key Countries, with sales, revenue, market share of top players in these Countries, from 2012 to 2017 (forecast), like  1 United States  2 Canada  3 Mexico  4 Germany  5 France  6 UK  7 Italy  8 Russia  9 China  10 Japan  11 India  12 Korea  13 Southeast Asia  14 Australia  15 Brazil  16 Middle East  17 Africa Split by Product Types, with sales, revenue, price, market share of each type, can be divided into  Manual ENT Chairs  Powered ENT Chairs Split by applications, this report focuses on sales, market share and growth rate of ENT Chairs in each application, can be divided into  Hospitals  Clinics 2017-2022 Global Top Countries ENT Chairs Market Report  1 ENT Chairs Market Overview  1.1 Product Overview and Scope of ENT Chairs  1.2 ENT Chairs Segment by Types  1.2.1 Global Sales Market Share of ENT Chairs by Types in 2015  1.2.2 Manual ENT Chairs  1.2.3 Powered ENT Chairs  1.3 ENT Chairs Segment by Applications  1.3.1 ENT Chairs Consumption Market Share by Applications in 2015  1.3.2 Hospitals  1.3.3 Clinics  1.4 ENT Chairs Market by Countries  1.4.1 United States Status and Prospect (2012-2022)  1.4.2 Canada Status and Prospect (2012-2022)  1.4.3 Germany Status and Prospect (2012-2022)  1.4.4 France Status and Prospect (2012-2022)  1.4.5 UK Status and Prospect (2012-2022)  1.4.6 Italy Status and Prospect (2012-2022)  1.4.7 Russia Status and Prospect (2012-2022)  1.4.8 China Status and Prospect (2012-2022)  1.4.9 Japan Status and Prospect (2012-2022)  1.4.10 India Status and Prospect (2012-2022)  1.4.11 Korea Status and Prospect (2012-2022)  1.4.12 Southeast Asia Status and Prospect (2012-2022)  1.4.13 Australia Status and Prospect (2012-2022)  1.4.14 Brazil Status and Prospect (2012-2022)  1.4.15 Mexico Status and Prospect (2012-2022)  1.4.16 Middle East Status and Prospect (2012-2022)  1.4.17 Africa Status and Prospect (2012-2022)  1.5 Global ENT Chairs Overview and Market Size (Value) (2012-2022)  1.5.1 Global Market ENT Chairs Overview  1.5.2 Global Market ENT Chairs Revenue (Million USD) and Growth Rate (2012-2022)  2 Global ENT Chairs Sales, Revenue (Value) and Market Share by Manufacturers  2.1 Global ENT Chairs Sales and Market Share in 2015 and 2016 by Manufacturers  2.2 Global ENT Chairs Revenue and Market Share by Manufacturers in 2015 and 2016  2.3 Global ENT Chairs Average Price by Manufacturers in 2015 and 2016  2.4 Global ENT Chairs Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers  2.5 ENT Chairs Market Competitive Situation and Trends  2.5.1 ENT Chairs Market Concentration Rate  2.5.2 ENT Chairs Market Share of Top 3 and Top 5 Manufacturers  2.5.3 Mergers & Acquisitions, Expansion  3 Global ENT Chairs Sales, Revenue (Value) by Countries, Type and Application (2012-2017)  3.1 Global ENT Chairs Sales, Revenue and Market Share by Countries (2012-2017)  3.1.1 Global ENT Chairs Sales and Market Share by Countries (2012-2017)  3.1.2 Global ENT Chairs Revenue and Market Share by Countries (2012-2017)  3.1.3 Global ENT Chairs Price by Countries (2012-2017)  3.2 Global ENT Chairs Sales, Revenue, Market Share and Price by Type (2012-2017)  3.2.1 Global ENT Chairs Sales and Market Share by Type (2012-2017)  3.2.2 Global ENT Chairs Revenue and Market Share by Type (2012-2017)  3.2.3 Global ENT Chairs Price by Type (2012-2017)  3.3 Global ENT Chairs Sales and Market Share by Application (2012-2017)  3.4 Global Market ENT Chairs Sales, Revenue, Price and Gross Margin (2012-2017) For more information or any query mail at [email protected]

Loading UMF collaborators
Loading UMF collaborators